Stimulation and inhibition of angiogenesis in diabetic retinopathy

Japanese Journal of Ophthalmology

Volumn 45, Issue 6, 2001, Pages 577-584

  Funatsu, Hideharu ^a   Yamashita, Hidetoshi ^b   Noma, Hidetaka ^a   Shimizu, Erika ^a   Yamashita, Tetsuji ^c   Hori, Sadao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Diabetic retinopathy; Endostatin; Platelet factor; Vascular endothelial growth factor

Indexed keywords

ENDOSTATIN; ENDOTHELIAL CELL GROWTH FACTOR; THROMBOCYTE FACTOR 4;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INHIBITION KINETICS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SAMPLING; STIMULATION;

ADULT; AGED; ANGIOGENESIS INDUCING AGENTS; COLLAGEN; DIABETIC RETINOPATHY; ENDOSTATINS; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLATELET FACTOR 4; RETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITRECTOMY; VITREOUS BODY;

EID: 0035695318     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(01)00420-8     Document Type: Article

References (33)

1. Mechanisms of retinal and choroidal neovascularization
2. Factors controlling ocular angiogenesis
3. Midperipheral fundus involvement in diabetic retinopathy
4. Diabetic retinopathy. A clinical review
5. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
6. Vascular endothelial growth factor is a secreted angiogenic mitogen
7. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases
8. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
9. Localization of vascular endothelial growth factor in human retina and choroid
10. Hypoxic regulation of vascular endothelial growth factor in retinal cells
11. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells
12. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes
13. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
14. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
15. Cytokines in the vitreous of patients with proliferative diabetic retinopathy
16. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
17. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
18. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders
19. Transforming growth factor β2 in the vitreous in proliferative diabetic retinopathy
20. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
21. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4
22. Platelet factor-4 inhibit the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms
23. Endostatin. Endogenous inhibitor of angiogenesis and tumor growth
24. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
25. Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter
26. Grading diabetic retinopathy from stereoscopic color fundus photographs. An extension of the modified Airlie House classification. ETDRS report number 10
27. Fundus photographic risk factors for progression of diabetic retinopathy. RTDRS report number 12
28. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer
29. Serum concentrations of endostatin in patients with vulvar cancer
30. Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves
31. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
32. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy